Prime Time for Proteomics in Pulmonary Arterial Hypertension Risk Assessment? is a research paper published in American Journal of Respiratory and Critical Care Medicine (2022). On theSindex it has a DataRank of 0.165. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.165
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIH
Grant: R01-HL141268
Medical Research Council
Grant: MR/K020919/1
NHLBI NIH HHS
Grant: R01 HL141268
National Institutes of Health
Grant: 5R01HL141268-05
Effects of DHEA in Pulmonary Hypertension (DiPH)
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals